---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-025805"
form_type: "8-K"
ticker: "CDT"
cik: "0001896212"
company_name: "CDT Equity Inc."
filed_at: "2024-07-01T23:59:59+00:00"
generated_at: "2026-06-01T00:12:28.888316+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Conduit Pharmaceuticals sets 2024 annual meeting for Oct 2; deadline for shareholder proposals July 11

## Summary
- Annual Meeting date: October 2, 2024; record date: August 20, 2024.
- Deadline for Rule 14a-8 shareholder proposals for inclusion in proxy is July 11, 2024.
- Company did not hold an annual meeting in 2023, triggering special deadline notice.
- Proposals must comply with SEC Rule 14a-8 and company bylaws.

## SEC filing metadata
- accession: 0001493152-24-025805
- form_type: 8-K
- ticker: CDT
- cik: 0001896212
- company_name: CDT Equity Inc.
- filed_at: 2024-07-01T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.08
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1896212/000149315224025805/0001493152-24-025805-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1896212/000149315224025805/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-025805
- JSON: https://secwatch.observer/filing/0001493152-24-025805.json
- Plain text: https://secwatch.observer/filing/0001493152-24-025805.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.